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A B S T R A C T
Purpose: The reasons why the mortality of patients with epilepsy is signiﬁcantly increased, even many
years after seizure onset, are not fully understood. The aim of this study was to compare the distribution
of the causes of death (COD) in an epilepsy population with that in the general population and with
previous ﬁndings in other epilepsy populations. In addition, we investigated the chronological
relationship between the onset of epilepsy and the onset of the diseases leading to death.
Methods: The COD for patients who were registered with a diagnosis of epilepsy at Stavanger University
Hospital from August 1 1995–July 31 2005 and died during the same period were obtained from the
Norwegian Cause of Death Registry and the hospital records were reviewed. The distribution of the
corresponding COD in the general population was obtained from Statistics Norway.
Results: At least 6.8% (18/266) of the deaths of epilepsy patients were directly related to seizures.
Epilepsy patients who had died from brain tumors (n = 46) were excluded from further analysis. Of the
remaining 220 deceased epilepsy patients, 39 (17.7%) had died from heart disease, compared with 27.8%
in the general population (p < 0.001). No other signiﬁcant differences in the distribution of COD in the
epilepsy population and the general population were identiﬁed. The majority of the epilepsy patients
who died from heart disease (71.8%) and cerebrovascular disease (72%) had cardiovascular disease prior
to seizure onset and in at least 43% of those who died from neoplasms the onset of malignancy occurred
before the ﬁrst seizure.
Conclusion: Comorbid diseases and underlying conditions were the major determinants of mortality in
this population of epilepsy patients. Conditions that are not caused by epilepsy or its treatment may
represent an important explanation for the previously documented excess mortality in people with
epilepsy.
 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Population-based studies have reported that the mortality of
individuals with epilepsy is two to three times higher than that of
the general population.1,2 The highest rates occur during the ﬁrst
years after seizure onset, mainly due to the underlying
conditions causing the epilepsy.3,4 However, a signiﬁcant excess
mortality has also been recorded, even many years after the
diagnosis of epilepsy.2 The reasons for this elevated death rate in
the epilepsy population are not fully understood, but a part of the
explanation may be a greater mortality associated with remote* Corresponding author at: Department of Neurology, Stavanger University
Hospital, P.O. Box 8100, 4068 Stavanger, Norway.
Tel.: +47 51518447; fax: +47 51519916.
E-mail addresses: auda@sus.no, dag.aurlien@lyse.net (D. Aurlien).
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http://dx.doi.org/10.1016/j.seizure.2012.05.015symptomatic epilepsy2 and also seizure-related deaths, of which
sudden unexpected death in epilepsy (SUDEP) is the most
common.5 Studies of cause-speciﬁc mortality rates in patients
with epilepsy have shown excess mortality from cerebrovascular
disease, heart disease, neoplasms and pneumonia.2,3,6 However,
the extent to which such diseases are related to the epilepsy and
its treatment per se, or represent independent comorbid
conditions, is unclear.
In the present study, we investigated the distribution of the
different causes of death (COD) in an epilepsy population and
compared this with the general population in the same catchment
area and also with reports from other populations with epilepsy. In
addition, in order to evaluate the contribution of comorbid
diseases to mortality in the epilepsy population, we studied the
chronological relationship between the onset of epilepsy and the
diseases leading to death.vier Ltd. All rights reserved.
Table 1
Proportionate mortality ratio (PMR) of patients with epilepsy and the general population.
Cause of death Population with epilepsy General population p-Valuea 95% CI
N PMR N PMR, excl. brain tumor N PMR N PMR, excl. brain tumor
Cerebrovascular 25 (9.4) 25 (11.4) 2514 (8.6) 2514 (8.6) 0.152 0.872–2.095
Heart disease 39 (14.7) 39 (17.7) 8095 (27.6) 8095 (27.8) <0.001 0.389–0.801
Brain tumors 46 (17.3) 218 (0.7)
Neoplasms, except brain tumors 56 (21) 56 (25.5) 7696 (26.2) 7696 (26.4) 0.743 0.693–1.301
Pneumonia 8 (3) 8 (3.6) 1431 (4.9) 1431 (4.9) 0.382 0.334–1.527
Suicide 2 (0.8) 2 (0.9) 130 (0.4) 130 (0.5) 0.261 0.348–8.440
Accidents 5 (1.9) 5 (2.3) 1252 (4.3) 1252 (4.3) 0.139 0.188–1.302
Other 85 (32) 85 (38.6) 7996 (27.3) 7996 (27.5) <0.001 1.255–2.203
Excl. seizure related deaths 67 (25.2) 67 (30.5) 7996 (27.3) 7996 (27.5) 0.322 0.858–1.557
Def. and prob. SUDEP 12 (4.5) 12 (5.5)
All SUDEP 19 (7.1) 19 (8.6)
Sum 266 (100) 220 (100) 29,332 (100) 29,114 (100)
CI, conﬁdence interval; excl., excluding.
a Comparisons excluding brain tumor.
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Stavanger University Hospital serves a population of about
300,000 in the southern part of Rogaland County, Norway. Data on
the distribution of age and gender of the living epilepsy patients
(N = 2480) at the end of the study period were obtained from the
database of Stavanger University Hospital and the corresponding
data for the general population of Rogaland per January 1 2005
(N = 393,104) from Statistics Norway (www.ssb.no).
Thedirectandthecontributingcausesofdeath(COD)ofall incident
andprevalentcasesthatwereregisteredwithadiagnosisofepilepsyat
Stavanger University Hospital in the ten-year period 01.08.1995–
31.07.2005 and who had died during the same period (N = 268) were
obtained retrospectively from the Norwegian Cause of Death Registry.
Two cases of SUDEP (one deﬁnite and one possible) that were
registeredwithadiagnosisofepilepsybeforethestudyperiod,butdied
duringthesameperiod,werealsoincluded.Afterreviewofthemedical
records to conﬁrm the epilepsy diagnosis, four cases were excluded.
This resulted in a total of 266 deceased patients with epilepsy. The
SUDEP cases were classiﬁed as deﬁnite, probable or possible.7,8 The
results of the study were based on the direct causes of death.
From Statistics Norway (www.ssb.no), we also obtained data on
the number of deaths, and also age and gender, among the general
population in the diagnostic categories ‘‘cerebrovascular’’ (ICD-9
430–438; ICD-10 I 60–69), ‘‘heart disease’’ (ICD-9 393–398, 410–
414, 415.0 and 420–429; ICD-10 I 05–I 09, I 20–I 25, I 27 and I 30–I
52), ‘‘neoplasm (excluding brain tumors)’’ (ICD-9 140–190, 192.2–
224 and 225.3–239; ICD-10 C00–C69, C70.1, C72.0, C72.1, C73–C97,Table 2
Distribution of causes of death in patients with epilepsy and in the general population
0–20 yearsa 21–40 yearsa 4
M F M F M
Patients with epilepsy
Cerebrovascular disease 0 0 0 0 
Cardiac disease 0 0 0 0 
Neoplasms except brain tumors 1 0 0 0 
Brain tumors 0 2 5 2 
Pneumonia 0 1 0 0 
Suicide 0 1 1 0 
Accients 0 0 1 0 
Other 8 9 3 11 
Sum 9 13 10 13 
General population
Cerebrovascular disease 0 0 14 2 
Cardiac disease 5 5 46 10 
Neoplasms except brain tumors 19 19 50 81 D32.1, D33.4, D34–D48), ‘‘brain tumours’’ (ICD-9 191, 192.0, 192.1,
225.0–2; ICD-10 C71, C72.2–C72.8, C70.0, D32.0, D33.0–D33.3),
‘‘pneumonia’’ (ICD-9 480–486; ICD-10 J12–J18), ‘‘suicide’’ (ICD-9
E950–E959; ICD-10 X6n), ‘‘accidents’’ (ICD-9 E800–E929; ICD-10
V0n–V99, W0n–X59, X8n, Y85–Y89) and ‘‘other’’.
Pearson chi-square and Fisher Exact tests were used to compare
the proportionate mortality ratio between deceased patients with
epilepsy and the deceased from the general population.
The study was approved by the Regional Committee of Medical
Research Ethics.
3. Results
The COD of the 266 deceased patients with epilepsy are
summarized in Table 1 and compared with those of 29,332 persons
in the general population.
Deaths from brain tumor were excluded from the analysis. Of
those remaining, 25.5% (56/220) of the deaths in patients with
epilepsy and 26.4% of the deaths in the general population were
caused by neoplasms. In at least 24 of the 56 (43%) individuals with
epilepsy that died from a malignant neoplasm (except brain
tumor), the onset of malignancy occurred prior to the ﬁrst seizure.
Signiﬁcantly fewer patients with epilepsy died from heart
disease than in the general population (Table 1; p < 0.001). Of the
patients with epilepsy that died from cardiac disease, 97.4% were
>60 years of age (Table 2). In at least 28/39 (71.8%) of the epilepsy
patients, the onset of cardiac disease or cerebrovascular disease
occurred before the onset of epilepsy..
1–60 yearsa 61–80 yearsa >80 yearsa Sum
 F M F M F
3 0 9 4 5 4 25
1 0 19 6 7 6 39
7 10 20 10 4 4 56
15 7 3 10 2 0 46
1 1 4 1 0 0 8
0 0 0 0 0 0 2
0 0 3 0 1 0 5
10 6 20 13 5 0 85
37 24 78 44 24 14 266
64 38 411 383 559 1043 2514
358 78 1814 1020 1819 2940 8095
584 670 2289 1647 1152 1185 7696
Table 2 (Continued )
0–20 yearsa 21–40 yearsa 41–60 yearsa 61–80 yearsa >80 yearsa Sum
M F M F M F M F M F
Brain tumors 6 4 10 9 46 20 55 50 6 12 218
Pneumonia 2 4 0 0 13 5 156 117 397 737 1431
Suicide 5 3 39 12 24 27 12 8 0 0 130
Accients 78 18 181 42 169 48 154 96 171 295 1252
Other 162 136 287 94 507 216 1530 1165 1470 2429 7996
Sum 277 189 627 250 1765 1102 6421 4486 5574 8641 29,332
F, females; M, males.
a Numbers of deaths within each category of age and gender.
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in the epilepsy population and the general population (Table 1;
p = 0.152). Of the 25 patients in the epilepsy population that died
from cerebrovascular disease, for 18 (72%) the epilepsy was
secondary to cerebrovascular disease, and 19 of these deaths were
acute stroke.
All patients with epilepsy that died from pneumonia had severe
underlying and/or comorbid predisposing conditions; four were
mentally disabled, of whom two had Down’s syndrome; two were
multimorbid elderly individuals with epilepsy secondary to
cerebrovascular disease, and two had neurodegenerative disease.
Of the two deaths from suicide in the epilepsy population, both
had experienced signiﬁcant psychosocial distress before seizure
onset.
It was not possible to determine whether or not the ﬁve fatal
accidents among the patients with epilepsy (Table 1) were causedTable 3
Distribution of age and gender in the patients with epilepsy at Stavanger university ho
Age 
0–20 years M 
% M 
% of all M 
F 
% F 
% of all F 
% 0–20 years 
21–40 years M 
% M 
% of all M 
F 
% F 
% of all F 
% 21–40 years 
41–60 years M 
% M 
% of all M 
F 
% F 
% of all F 
% 41–60 years 
61–80 years M 
% M 
% of all M 
F 
% F 
% of all F 
% 61–80 years 
>80 years M 
% M 
% of all M 
F 
% F 
% of all F 
% >80 years 
F, females; M, males.by seizures. However, there were 12 cases of deﬁnite and probable
SUDEP, two cases of status epilepticus, and one drowning that was
considered to be seizure-related. In addition, in three of the seven
possible SUDEP cases, aspiration of gastric contents was sus-
pected,7 suggesting that the deaths of these patients were seizure-
related. When these cases of aspiration of gastric contents were
also included, the proportion of deaths directly related to seizures
in this population of epilepsy patients was at least 6.8% (18/266).
Furthermore, if the remaining four possible cases of SUDEP and the
ﬁve deaths from accidents were also assumed to be seizure-
related, then the proportion of seizure-related deaths could be as
high as 10.2% (27/266).
If seizure-related deaths in the epilepsy population were
excluded from the category ‘‘other’’, then the proportion of deaths
in this category did not differ signiﬁcantly in the epilepsy
population from in the general population (Table 1).spital (1995–2005) compared with the general population of Rogaland county.
Patients with epilepsy General population
306 61,084
48.6 51.2
24.3 31.1
323 58,144
51.4 48.8
26.5 29.6
25.4 30.3
392 57,384
47.3 50.9
31.1 29.2
437 55,375
52.7 49.1
35.8 28.2
33.4 28.7
331 50,949
55.4 51.3
26.2 25.9
266 48,371
44.6 48.7
21.8 24.6
24.1 25.3
162 22,619
52.9 47
12.8 11.5
144 25,553
47.1 53
11.8 13
12.3 12.3
70 4515
58.8 33.1
5.6 2.3
49 9110
41.2 66.9
4 4.6
4.8 3.5
N = 2480 N = 393,104
M:1261 (50.8%) M:196,551 (50%)
F:1219 (49.2%) F:196,553 (50%)
Table 4
Proportionate mortality ratio in patients with epilepsy and in the general population.a
Cause of death Patients with epilepsy General population,
Rogaland county, Norway
SUS Warsaw9 USA10,11 UK12 Sweden6 UK13 UK14
Cerebrovascular 9.4 12 14 13 14 6 5 8.6
Heart disease 14.7 16 19 8 16 10 19 27.6
Neoplasms, all 38.3 24 20 35 16 12 26 26.9
Brain tumors 17.3 15 8 9 4 0,6 0,8 0.7
Pneumonia 3 8 8 12 5 12 25 4.9
Suicide 0.8 7 1.6 0.6 1.3 3.3 0 0.4
Accidents 1.9 4 6 3 7 3 4.3
Seizure-related 6.8–10.2 10 6 1.3 31 12
SUDEP 4.5 4 0 6
Other 32 15 25 30 41 18 5 27.3
SUDEP, sudden unexpected death in epilepsy (only deﬁnite and probable cases included); SUS, Stavanger University Hospital.
a Table modiﬁed from Forsgren et al.3
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the ten-year period, 2480 were alive at the end of the period. The
distributions of age and gender in the population with epilepsy and
in the general population are shown in Table 3.
4. Discussion
In this study, the COD in patients with epilepsy and in the
general population in the same catchment area have been
compared, and our ﬁndings add important knowledge on the
causes of mortality in people with epilepsy. The distribution of the
COD were generally similar to previously published ﬁndings 6,9–14
(Table 4), and, except from a lower proportion of deaths from
cardiac disease in the epilepsy patients compared with the general
population, no signiﬁcant differences of proportionate mortality
between the two populations were identiﬁed. However, the
majority of epilepsy patients that died from cardiac or cerebro-
vascular disease had onset of vascular disease prior to the onset of
epilepsy and, similarly, a signiﬁcant proportion (43%) of those that
died from neoplasms had onset of malignancy before seizure onset.
This chronological relationship has, to our knowledge, not been
previously shown in a clinical study. Our results may suggest that
comorbid conditions that are not caused by epilepsy per se or its
treatment can explain the previously documented excess mortality
in epilepsy.
In a recent population based study2 from the UK, the overall
standardized mortality ratio (SMR) for individuals with deﬁnite
seizures was 2.6. Our study design does not allow calculation of the
SMR, but our objective was to elucidate those conditions that may
contribute to the increased mortality and assess their relative
signiﬁcance. This is important as the high mortality could be due
to: (a) brain diseases causing both epilepsy and early death; (b)
direct epilepsy-related deaths; and (c) indirect effects due to the
epilepsy itself or to the use of antiepileptic drugs (AEDs). In
addition, comorbid conditions may play a role because a number of
comorbidities, including stroke,15 are more prevalent in epilepsy
patients than in the general population.
Brain diseases that can cause both epilepsy and premature
death include primary brain tumors and cerebrovascular disease.
In our study, mortality due to brain tumors was, as expected,
considerably higher in the epilepsy patients than in the general
population. Previous studies have reported a signiﬁcantly in-
creased mortality in epilepsy from cerebrovascular disease2,3 and
in our study the proportion of deaths due to cerebrovascular
disease was also slightly, but not signiﬁcantly, elevated compared
with the general population. However, we found that epilepsy was
secondary to cerebral stroke in 18 of the 25 patients that died from
cerebrovascular disease, indicating that the epilepsy could not
have had a causal association with the ﬁrst stroke in these cases.Although a previous study16 has documented that the risk of a ﬁrst
stroke in patients with seizure onset at or after the age of 60 was
signiﬁcantly higher than in controls, that study did not consider
the presence of diabetes, hypertension, hypercholesterolemia and
other risk factors for stroke. Thus it is difﬁcult to reach a ﬁrm
conclusion from that data that the increased risk of stroke in the
epilepsy population was due to the epilepsy itself.
Similarly, another important ﬁnding in our study was that in at
least 72% of those who died from cardiac disease, the onset of
vascular disease occurred prior to the onset epilepsy. Again, this
indicates that there was no causal relationship between epilepsy
and the onset of vascular disease in these patients. Some previous
studies of cause-speciﬁc mortality in epilepsy have indicated an
increased mortality from cardiac disease2,3,6 and treatment with
old-generation AEDs has been linked to unfavorable changes in
blood lipids and other vascular risk factors.17,18 However, a study
on risk factors for coronary heart disease in males between 30 and
50 years of age and suffering from chronic epilepsy concluded that
there was no signiﬁcant difference in comparison with healthy
controls.19 Additionally, the elevated death rate from cardiac
disease in epilepsy patients has been found to occur only in
patients <65 years of age.3,11 Interestingly, in our study only one of
the deaths from cardiac disease occurred in a patient <60 years of
age, and three were <65 years old. One possible explanation for our
ﬁnding may be that patients with epilepsy receive a more thorough
medical follow-up than the general population, and this includes a
focus on risk factors for cardiovascular disease. In our opinion,
neither the results from our study nor the previous literature
contains convincing evidence that epilepsy per se or its treatment
increases the risk of death from vascular disease.
An SMR of 2.6 from malignant neoplasms, excluding brain
tumors, was found in patients with deﬁnite epilepsy in the UK-
based study after a total follow-up up to 25 years.2 A previous
study12 from the same cohort with a median follow up of 6.9 years
reported an SMR of 3.4 for the same COD. However, in our study,
when deaths from brain tumors were excluded, the proportion due
to neoplasms was about the same in the population with epilepsy
as in the general population, and for over 40% of those with
epilepsy that died from a malignant neoplasm (except brain
tumor), the onset of malignancy occurred prior to the ﬁrst seizure.
Thus, it seems unlikely that epilepsy per se or its treatment has a
signiﬁcant causal effect regarding mortality from neoplasms.
In our study, all those epilepsy patients that died from
pneumonia had severe underlying or comorbid conditions.
Seizure-related aspiration has previously been suggested as a
possible explanation for the increased mortality from pneumonia
in people with epilepsy, but this does not explain why this occurs
even in seizure-free patients.2 Our ﬁndings suggest that comorbid
or underlying conditions may be at least contributory.
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suicidality.20,21 However, the anticipated class effect of AEDs
increasing the risk of suicidality has been questioned,20 as well as
the aetiologic role of epilepsy as responsible for the increased risk
of suicide.21 Both suicide cases in our study had experienced
signiﬁcant psychosocial distress prior to the onset of seizures and
one of the two was not treated with an AED. Thus, our study
provides no support for the concept that AED use increases the risk
of suicide.
At least 6.8%, and perhaps as high as over 10%, of the deaths
among the epilepsy population in our study were directly related to
seizures. Other than these, the deaths were caused by comorbid
conditions, of which a signiﬁcant proportion was present prior to the
onset of epilepsy. This suggests that comorbid conditions unrelated
to epilepsy may explain the previously reported signiﬁcantly
increased SMR in the epilepsy population.1–3 This suggestion
concurs with previous ﬁndings of higher mortality in symptomatic
epilepsy than in cryptogenic or idiopathic epilepsy.1,2,12,22
During the 10-year period of the study, the epilepsy patients in
the catchment area of Stavanger University Hospital received care
from hospital specialists in cooperation with general practitioners.
Therefore, although the present study is hospital-based, the results
from a similar population based study in the same catchment area
would probably have produced similar results. The distribution of
age and gender in the epilepsy population at risk was also fairly
similar to that of the general population.
One limitation of this study is the retrospective design and the
lack of classiﬁcation of the epilepsy syndromes of the cohort. This
means that the possibility that some of the epilepsy diagnoses may
have been incorrect cannot be excluded. Furthermore, as our
cohort consisted of both prevalent and incident cases this may
have affected the results, as mortality in epilepsy is higher during
the ﬁrst years after seizure onset.3,4 As we have not estimated the
SMR of the epilepsy population in this study, our results should not
be interpreted as documenting a reduced risk of dying from cardiac
disease in people with epilepsy, nor as a demonstration of an equal
risk of dying from the other COD that were investigated.
5. Conclusions
Our ﬁndings suggest that comorbid conditions not caused by
epilepsy or its treatment are more important in increasing the
mortality in the epilepsy population than previously realized.
Apart from those deaths that were directly related to seizures,
neither our results nor the results from previous studies provide
convincing evidence that the diagnosis of epilepsy per se imposes a
signiﬁcantly increased risk of premature death.
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